Home > Insider Trading > Filing (0001209191-20-055042)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1741830	Kronos Bio Inc.	KRON	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1190578	C John Martin	C/O Kronos Bio, Inc. 1300 So. El Camino Real, Suite 300 San Mateo CA 94402		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-10-14	914,333	$0.00	914,333	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-10-14	756,971	$0.00	1,671,304	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-10-14	205,260	$16.15	1,876,564	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-10-14	75,800	$19.00	1,952,364	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series Seed Preferred Stock	Disposition	2020-10-14	866,667	$0.00	914,333	$0.00
Common Stock	Series A Preferred Stock	Disposition	2020-10-14	717,509	$0.00	756,971	$0.00
Common Stock	Convertible Promissory Note	Disposition	2020-10-14	0	$0.00	205,260	$16.15

Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
	No	4	C	Indirect
	No	4	C	Indirect
2022-02-20	No	4	C	Indirect

Footnotes

Each share of Series Seed Preferred Stock and Series A Preferred Stock (the "Preferred Stock") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.
The securities are held by Nexus Development PA, LLC ("Nexus"). Dr. Martin currently serves as the President of Nexus. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
The convertible promissory note automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering.